Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Phoenix, Arizona
  • +119 more
Feb 1, 2023

Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

Completed
  • Advanced Solid Tumors
  • +17 more
  • San Diego, California
  • +3 more
Jan 27, 2023

Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

Recruiting
  • Gastric Cancer
  • +8 more
  • Scottsdale, Arizona
  • +9 more
Dec 22, 2022

Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029

Terminated
Has Results
  • Colorectal Cancer
  • +6 more
  • GEN1029 (HexaBody®-DR5/DR5)
  • New Haven, Connecticut
  • +5 more
Nov 11, 2022

Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +11 more
  • Tucson, Arizona
  • +11 more
Dec 2, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T

Recruiting
  • Breast Cancer
  • +8 more
  • San Francisco, California
  • +4 more
Oct 26, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,

Recruiting
  • Solid Tumor
  • +7 more
  • BNT141
  • +2 more
  • Duarte, California
  • +10 more
Aug 23, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)

Recruiting
  • Advanced Solid Tumor
  • +18 more
  • PT199
  • Anti-PD-1 monoclonal antibody
  • Huntersville, North Carolina
  • +2 more
Aug 10, 2022

Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T

Active, not recruiting
  • Urinary Bladder Cancer
  • +9 more
  • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
  • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
  • Miami, Florida
  • +10 more
Aug 9, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma Trial in Houston (LVGN3616 + LVGN6051 +

Recruiting
  • Metastatic Esophageal
  • +7 more
  • LVGN3616 + LVGN6051 + Nab-Paclitaxel
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

Recruiting
  • ER+ Breast Cancer
  • +8 more
  • Sarasota, Florida
  • +3 more
Jun 8, 2022

Advanced or Metastatic Solid Tumors, Ovarian Cancer, Gastric Cancer Trial in United States (NC410)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +3 more
  • Bethesda, Maryland
  • +4 more
May 25, 2022

Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

Recruiting
  • Solid Tumor, Adult
  • +11 more
  • New Haven, Connecticut
  • +3 more
May 9, 2022

Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

Recruiting
  • Thyroid
  • +18 more
  • New Haven, Connecticut
  • +6 more
Apr 8, 2022